These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32986422)

  • 41. The dopamine receptor agonist apomorphine stabilizes neurotoxic α-synuclein oligomers.
    Lima VA; Esquinelato R; Carmo-Gonçalves P; Nascimento LAD; Lee H; Eliezer D; Romão L; Follmer C
    FEBS Lett; 2022 Feb; 596(3):309-322. PubMed ID: 34928512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.
    Cullen V; Lindfors M; Ng J; Paetau A; Swinton E; Kolodziej P; Boston H; Saftig P; Woulfe J; Feany MB; Myllykangas L; Schlossmacher MG; Tyynelä J
    Mol Brain; 2009 Feb; 2():5. PubMed ID: 19203374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spontaneous nucleation and fast aggregate-dependent proliferation of α-synuclein aggregates within liquid condensates at neutral pH.
    Dada ST; Hardenberg MC; Toprakcioglu Z; Mrugalla LK; Cali MP; McKeon MO; Klimont E; Michaels TCT; Knowles TPJ; Vendruscolo M
    Proc Natl Acad Sci U S A; 2023 Feb; 120(9):e2208792120. PubMed ID: 36802433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.
    Íñigo-Marco I; Valencia M; Larrea L; Bugallo R; Martínez-Goikoetxea M; Zuriguel I; Arrasate M
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8274-E8283. PubMed ID: 28900007
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Caputo A; Liang Y; Raabe TD; Lo A; Horvath M; Zhang B; Brown HJ; Stieber A; Luk KC
    eNeuro; 2020; 7(4):. PubMed ID: 32788297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.
    Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M
    J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity.
    Chutna O; Gonçalves S; Villar-Piqué A; Guerreiro P; Marijanovic Z; Mendes T; Ramalho J; Emmanouilidou E; Ventura S; Klucken J; Barral DC; Giorgini F; Vekrellis K; Outeiro TF
    Hum Mol Genet; 2014 Dec; 23(25):6732-45. PubMed ID: 25092884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
    Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
    ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.
    Bennett NK; Chmielowski R; Abdelhamid DS; Faig JJ; Francis N; Baum J; Pang ZP; Uhrich KE; Moghe PV
    Biomaterials; 2016 Dec; 111():179-189. PubMed ID: 27736702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination for Parkinson's disease.
    Schneeberger A; Mandler M; Mattner F; Schmidt W
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S11-3. PubMed ID: 22166404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation.
    Torpey JH; Meade RM; Mistry R; Mason JM; Madine J
    Front Neurosci; 2020; 14():561462. PubMed ID: 33177976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.
    Luna E; Decker SC; Riddle DM; Caputo A; Zhang B; Cole T; Caswell C; Xie SX; Lee VMY; Luk KC
    Acta Neuropathol; 2018 Jun; 135(6):855-875. PubMed ID: 29502200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inducible Alpha-Synuclein Expression Affects Human Neural Stem Cells' Behavior.
    Zasso J; Ahmed M; Cutarelli A; Conti L
    Stem Cells Dev; 2018 Jul; 27(14):985-994. PubMed ID: 29669468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. α-Synuclein-Confocal Nanoscanning (ASYN-CONA), a Bead-Based Assay for Detecting Early-Stage α-Synuclein Aggregation.
    Pérez-Pi I; Evans DA; Horrocks MH; Pham NT; Dolt KS; Koszela J; Kunath T; Auer M
    Anal Chem; 2019 May; 91(9):5582-5590. PubMed ID: 30964656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein trapping leads to altered synaptic proteostasis in synucleinopathies.
    Santos PI; Outeiro TF
    FEBS J; 2020 Dec; 287(24):5294-5303. PubMed ID: 32400966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.
    Jinn S; Drolet RE; Cramer PE; Wong AH; Toolan DM; Gretzula CA; Voleti B; Vassileva G; Disa J; Tadin-Strapps M; Stone DJ
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2389-2394. PubMed ID: 28193887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity.
    Tenreiro S; Rosado-Ramos R; Gerhardt E; Favretto F; Magalhães F; Popova B; Becker S; Zweckstetter M; Braus GH; Outeiro TF
    Hum Mol Genet; 2016 Jan; 25(2):275-90. PubMed ID: 26586132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. α-Synuclein Interaction with Lipid Bilayer Discs.
    Dubackic M; Liu Y; Kelley EG; Hetherington C; Haertlein M; Devos JM; Linse S; Sparr E; Olsson U
    Langmuir; 2022 Aug; 38(33):10216-10224. PubMed ID: 35952001
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Carmo-Gonçalves P; Romão L; Follmer C
    ACS Chem Neurosci; 2020 Nov; 11(21):3541-3548. PubMed ID: 33080132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers.
    Dokleja L; Hannula MJ; Myöhänen TT
    Neurosci Lett; 2014 Nov; 583():37-42. PubMed ID: 25240592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.